Tafluprost ethyl amide
Tafluprost ethyl amide is a prostaglandin derivative. Tafluprost ethyl amide is capable of reducing intraocular pressure (IOP) and influencing eyelash growth. Tafluprost ethyl amide can be used in antiglaucoma ophthalmic compositions[1].
Product Specifications
CAS Number
[1185851-52-8]
UNSPSC
12352005
Hazard Statement
H302, H360
Target
Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/tafluprost-ethyl-amide.html
Purity
99.56
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
FC(COC1=CC=CC=C1)(F)/C=C/[C@@H]2[C@H]([C@H](C[C@H]2O)O)C/C=C\CCCC(NCC)=O
Molecular Formula
C24H33F2NO4
Molecular Weight
437.52
Precautions
H302, H360
References & Citations
[1]Krupa M, et al. A Novel Convergent Synthesis of the Potent Antiglaucoma Agent Tafluprost. Molecules. 2017 Jan 31;22 (2) :217.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
OLIG1, CT (OLIG1, BHLHB6, BHLHE21, Oligodendrocyte transcription factor 1, Class B basic helix-loop-helix protein 6, Class E basic helix-loop-helix protein 21)
OLIG1, CT (OLIG1, BHLHB6, BHLHE21, Oligodendrocyte transcription factor 1, Class B basic helix-loop-helix protein 6, Class E basic helix-loop-helix protein 21)
FAM18A Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Mouse Monoclonal PSGL-1/CD162 Antibody (PSGL1/1601) [Alexa Fluor 350]